PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 16, 2018European Heart Journal

The Year in Cardiology 2018: Valvular Heart Disease

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with valvular heart disease, including aortic stenosis, mitral regurgitation, and tricuspid valve…

Design

Review

Key result

Transcatheter aortic valve implantation procedures steeply increased, with in-hospital mortality in Germany being similar for TAVI (2.6%) and SAVR (2.9%) in 2016 despite different risk profiles.

Authors

WWWojciech WojakowskiHBHelmut Baumgartner

Discussion

Loading...

Member takes

Overview

Transcatheter studies now dominate VHD literature; extends the documented shift in research priorities toward device therapies.

Structured PICO

P
Population
Patients with valvular heart disease, including aortic stenosis, mitral regurgitation, and tricuspid valve disease.
I
Intervention
Transcatheter and surgical interventions for valvular heart disease (e.g., TAVI, SAVR, TMVR, edge-to-edge repair).

The 2018 year in review highlights the rapid expansion of TAVI into lower-risk populations and complex anatomies, alongside emerging transcatheter therapies for mitral and tricuspid disease.

Cite This Study

Wojakowski et al. (2018) conducted a review in Valvular heart disease. Transcatheter and surgical treatments was evaluated. Transcatheter aortic valve implantation procedures steeply increased, with in-hospital mortality in Germany being similar for TAVI (2.6%) and SAVR (2.9%) in 2016 despite different risk profiles.

synapsesocial.com/papers/6a6d084135aa2c282cdfc377https://doi.org/10.1093/eurheartj/ehy893
View Full Paper
Ask AI
Bookmark
Share